43
Views
7
CrossRef citations to date
0
Altmetric
Review

Current migraine management – patient acceptability and future approaches

&
Pages 1043-1057 | Published online: 05 Dec 2008

References

  • AmbrosiniAMaertens de NoordhoutA2001Neuromuscular transmission in migraine: a single fiber EMG study in clinical subgroupsNeurology5610384311320175
  • Andlin-SobockiPJönssonBWittchenHU2005Cost of disorders of the brain in EuropeEur J Neurol12Suppl 112715877774
  • AyataCJinHKudoC2006Suppression of cortical spreading depression in migraine prophylaxisAnn Neurol596526116450381
  • BendtsenL2003Amitriptyline in the treatment of primary headachesExp Rev Neurother316573
  • BergJStovnerLJ2005Cost of migraine and other headaches in EuropeEur J Neurol12Suppl 1596215877781
  • BøeMGMyglandASalvesenR2007Prednisolone does not reduce withdrawal headache: a randomized, double-blind studyNeurology69263117475943
  • BoureauFKapposLSchoenenJ2000A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraineInt J Clin Pract54281610954953
  • BrandesJLKudrowDStarkSR2007Sumatriptan-naproxen for acute treatment of migraine: a randomized trialJAMA29714435417405970
  • BreslauNLiptonRBStewartWF2003Comorbidity of migraine and depression: Investigating potential etiology and prognosisNeurology6013081212707434
  • BurnsBWatkinsLGoadsbyPJ2007Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patientsLancet369109910617398309
  • CammarataDKruszJC2005Memantine: Novel mechanism for migraine and headache prophylaxisHeadache45820
  • ClouseJCOsterhausJT1994Healthcare resource use and costs associated with migraine in a managed healthcare settingAnn Pharmacother8659648069007
  • ColmanIBrownMDInnesGD2005Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literatureAnn Emerg Med4539340115795718
  • D’AmicoDLantéri-MinetM2006Migraine preventive therapy: selection of appropriate patients and general principles of managementExpert Rev Neurother611475716893343
  • D’AndreaGGranellaFCadaldiniM1999Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot studyCephalalgia1964610099862
  • DaviesGMSantanelloNLiptonR2000Determinants of patient satisfaction with migraine therapyCephalalgia205546011075838
  • De LignieresBMauvais-JavisPMasJML1986Prevention of menstrual migraine by percutaneous oestradiolBMJ29315403099950
  • DelstancheSSchoenenJ2006La toxine botulinique dans le traitement des céphaléesNeurone1114854
  • Di MondaVNicolodiMAloisioA2003Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trialHeadache438354412940804
  • DiamondSBigalMESilbersteinS2007Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention studyHeadache473556317371352
  • DienerHPfaffenrathVPagelerL2005The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group studyCephalalgia257768716162254
  • DienerHCBussoneGde LianoH2004aPlacebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacksCephalalgia249475415482357
  • DienerHCDahlofCGOlesenJTfelt-HansenPWelchKMA1999Headache associated with chronic use of substancesThe Headaches2nd edLippincott, Williams and WilkinsPhiladelphia, USA8718
  • DienerHCKronfeldKBoewingG2006Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trialLancet Neurol5310616545747
  • DienerHCPfaffenrathVSchnitkerJ2005Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention – a randomized, double-blind, multicentre, placebo-controlled studyCephalalgia2510314116232154
  • DienerHCRahlfsVWDaneschU2004bThe first placebo controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteriaEur Neurol51899714752215
  • DienerHCfor the ASASUMAMIG Study Group1999Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group studyCephalalgia19581810448545
  • DodickDLiptonRBMartinV2004Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraineHeadache444142515147249
  • EggersSD2007Migraine-related vertigo: diagnosis and treatmentCurr Pain Headache Rep112172617504649
  • EversSAfraJFreseA2006EFNS guidelines on the drug treatment of migraine – report of an EFNS task forceEur J Neurol135607216796580
  • EversSGralowIBauerB1999Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidmiologic studyClin Neuropharmacol22201610442248
  • EversSPothmannRUberallM2001Therapie idiopathischer Kopfschmerzen im KindesalterNervenheilkunde2030615
  • EversS1999Drug treatment of migraine in children. A comparative reviewPaediatr Drugs171810937475
  • FacchinettiFFioroniLSancesG1989Naproxen sodium in the treatment of premenstrual symptoms: a placebo-controlled studyGynecol Obstet Invest2820582695413
  • FaccoELiguoriAPettiFTraditional acupuncture in migraine: a controlled, randomized studyHeadacheIn press
  • FerrarriMDRoonKILiptonRB2001Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trialsLancet35816687511728541
  • FumalASchoenenJ2008Tension-type headache: current research and clinical managementLancet Neurol7708318093564
  • Garcia RodriguezLAJickH1994Risk of upper gastrintestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugsLancet343769727907735
  • GoadsbyP2006Recent advances in the diagnosis and management of migraineBMJ33225916399733
  • GoadsbyPJEdvinssonL1993The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and catsAnn Neurol3348568388188
  • GoadsbyPJFerrariMDOlesenJ2007Double-blind placebo-controlled trial of tonabersat in the preventive management of migraineCephalalgia2711956
  • GoadsbyPJLiptonRBFerrariMD2002Migraine-current understanding and treatmentN Engl J Med242577011807151
  • GoadsbyPJ2007aRecent advances in understanding migraine mechanisms, molecules and therapeuticsTrends Mol Med13394417141570
  • GoadsbyPJ2007bEmerging therapies for migraineNat Clin Pract Neurol36101917982431
  • GoldsteinDJRoonKIOffenWW2001Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trialLancet3581230411675061
  • GoldsteinJSilbersteinSDSaperJR2006Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled studyHeadache464445316618262
  • GuptaPSinghSGoyalV2007Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study)Headache474021217371357
  • HaanJKorsEEVanmolkotKR2005Migraine genetics: an updateCurr Pain Headache Rep92132015907261
  • HoTWMannixLKFanX2008Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraineNeurology7013041217914062
  • HuXHMarksonLELiptonRB1999Burden of migraine in the United States: disability and economic costsArch Intern Med159813810219926
  • HumphreyPPAGoadsbyPJ1994The mode of action of sumatriptan is vascular? A debateCephalalgia14401107697699
  • International Headache Society1988Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial painCephalalgia8Suppl 7196
  • JensenRStovnerLJ2008Epidemiology and comorbidity of headacheLancet Neurol73546118339350
  • KarliNZarifogluMCalisirN2005Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology?Cephalalgia254445115910569
  • KrymchantowskiAVBarbosaJS2000Prednisone as initial treatment of analgesic-induced daily headacheCephalalgia201071310961766
  • LamplCKatsaravaZDienerHC2005Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with auraJ Neurol Neurosurg Psychiatry761730216291905
  • LangmanMJSWeilJWainwrightP1994Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugsLancet343107587909103
  • LassenLHAshinaMChristiansenINitric oxide synthase inhibition in migraineLancet199734940129033475
  • LeãoAAP1944Spreading depression of activity in the cerebral cortexJ Neurophysiol735990
  • LenarduzziPSchoenenJSianard-GainkoJ1988Efficacy of clomipramine during the weaning period in drug abuse headaches: a blinded studyNew Trends Clin NeuropharmII162
  • LeonardiMSteinerTJScherAT2005The global burden of migraine: measuring disability in headache disorders with WHO‘s Classification of Functioning, Disability and Health (ICF)J Headache Pain64294016388337
  • LewisDAshwalSHersheyA2004Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology SocietyNeurology6322152415623677
  • LindeKStrengAJürgensS2005Acupuncture for patients with migraine: a randomized controlled trialJAMA29321182515870415
  • LiptonRBBigalMEDiamondMAMPP Advisory Group2007Migraine prevalence, disease burden, and the need for preventive therapyNeurology68343917261680
  • LiptonRBGöbelHEinhauplKM2004Petasites hybridus root (butterbur) is an effective preventive treatment for migraineNeurology632240415623680
  • LiptonRBStewartWFDiamondS2001Prevalence and burden of migraine in the United States: data from the American Migraine Study IIHeadache416465711554952
  • MacGregorA2007aMenstrual migraine: a reviewJ Fam Plann Reprod Health Care33364717389095
  • MacGregorA2007bMigraine in pregnancy and lactation: a clinical reviewJ Fam Plann Reprod Health Care33839317407673
  • MagisDAllenaMBollaM2007Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot studyLancet Neurol63142117362835
  • MatharuMSBartschTWardN2004Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET studyBrain1272203014607792
  • MathewNTFrishbergBMGawelMBOTOX CDH Study Group2005Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trialHeadache4529330715836565
  • MauskopA2005Vagus nerve stimulation relieves chronic refractory migraine and cluster headachesCephalalgia2582615658944
  • MoskowitzMA2007Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatmentFunct Neurol22133617925161
  • NatteroGAllaisGDe LorenzoC1991Biological and clinical effects of naproxen sodium in patients with menstrual migraineCephalalgia11Suppl 1120121742776
  • NCT00269022 [http://www.clinicaltrials.gov/ct/show/NCT00269022?order=1]
  • NebeJHeierMDienerHC1995Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placeboCephalalgia1553158706118
  • NestoriucYMartinA2007Efficacy of biofeedback for migraine: A meta-analysisPain1281112717084028
  • NewmanLMannixLKLandyS2001Naratriptan as short-term prophylaxis in menstrually associated migraine: a randomised, double-blind, placebo-controlled studyHeadache412485611264684
  • ObermannMKatsaravaZ2007Management of medication-overuse headacheExp Rev Neurother7114555
  • OlesenJBousserMGDienerHC2006New appendix criteria open for a broader concept of chronic migraineCephalalgia26742616686915
  • OlesenJDienerHCHusstedtIWBIBN 4096 BS Clinical Proof of Concept Study Group2004.Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraineN Engl J Med35011041015014183
  • OsterhausJTGuttermanDLPlachetkaJR1992Healthcare resource and lost labour costs of migraine headache in the USPharmacoeconomics2677610146980
  • PagelerLKatsaravaZDienerHC2008Prednisone vs placebo in withdrawal therapy following medication overuse headacheCephalalgia28152618039339
  • PatelNVBigalMEKolodnerKB2004Prevalence and impact of migraine and probable migraine in a health planNeurology631432815505161
  • PeetersMGunthorpeMJStrijbosPJ2007Effects of pan – and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: Therapeutic potential for migraineJ Pharmacol Exp Ther3215647217267580
  • PeikertAWilimzigCKöhne-VollandR1996Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized studyCephalalgia16257638792038
  • PeresMFSilbersteinSMoreiraF2007Patients’ preference for migraine preventive therapyHeadache47540517445103
  • PradelFGSubediPVargheseAA2006Does earlier headache response equate to earlier return to functioning in patients suffering from migraine?Cephalalgia264283516556244
  • PringsheimTDavenportWJDodickD2008Acute treatment and prevention of menstrually related migraine headache: Evidence-based reviewNeurology7015556318427072
  • RaskinNH1986Repetitive intravenous dihydroergotamine as therapy for intractable migraineNeurology3699573520384
  • RasmussenBKJensenROlesenJ1991A population-based analysis of the criteria of the International Headache SocietyCephalalgia11129341889068
  • RasmussenBK2001Epidemiology of headacheCephalalgia21774711595011
  • ReljaMPooleACSchoenenJ2007A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headachesCephalalgia2749250317428299
  • SadlerRMPurdyRARaheyS2002Vagal nerve stimulation aborts migraine in patient with intractable epilepsyCephalalgia22482412133049
  • SándorPSAmbrosiniAAgostiR2001bGenetics of migraine and possible links to neurophysiological abnormalitiesPain Clinical Updates914
  • SándorPSDi ClementeLCoppolaG2005Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trialNeurology64713515728298
  • SándorPSMasciaASeidelL2001aSubclinical cerebellar impairment in the common types of migraine: A 3-dimensional analysis of reaching movementsAnn Neurol4966872
  • SangCNRamadanNMWallihanRG2004LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well tolerated in acute migraineCephalalgia2459660215196302
  • SargentJSolbachPDamasioH1985A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headacheHeadache2532043902723
  • SchoenenJBulckeJCaekebekeJ1994Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal studyCephalalgia1455638200027
  • SchoenenJBurettePMaterneP2006bPatent foramen ovale and migraine, a fortuitus association or a causal relationship?Rev Med Liege61362816910262
  • SchoenenJDe KlippelNGiurgeaS2008On behalf of the Belgian Headache Society. Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodyniaCephalalgia28109510518644036
  • SchoenenJDi ClementeLCoppolaGOlesenJSilbersteinSDTfelt-HansenP2004Other prophylactic anti-migraine agents: riboflavin, feverfew, magnesium, Botulinum toxin, and calcium antagonistsPreventive Pharmacotherapy of Headache DisordersOxfordUniversity Press12133
  • SchoenenJJacquyJLenaertsM1998Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trialNeurology50466709484373
  • SchoenenJWangWGoadsbyPJSilbersteinSJ1997Tension-type HeadacheHeadacheBostonButterworth-Heinemann177200
  • SchoenenJ1998The pathophysiology of migraine: a review based on the literature and on personal contributionsFunct Neurol137159584870
  • SchoenenJ2006aFuture preventive therapy: are there promising drug targets?Headache Currents310811
  • SchoonmanGGEversDJTerwindtGM2006The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patientsCephalalgia2612091316961788
  • SchraderHStovnerLJHeldeG2001Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover studyBMJ322192211141144
  • SchürksMDienerHCGoadsbyP2008Update on the prophylaxis of migraineCurr Treat Options Neurol1020918325296
  • SilbersteinSDElkindAHSchreiberC2004A randomized trial of frovatriptan for the intermittent prevention of menstrual migraineNeurology63261915277618
  • SilbersteinSDStarkSRLucasSM2005Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebocontrolled trialMayo Clin Proc8011263716178492
  • SilbersteinSDfor the US Headache Consortium2000Practice parameter: Evidence Based guidelines for migraine headache (an Evidence-based review)Neurology557546210993991
  • SilbertseinSDOlesenJBousserMG2005International Headache Society. The International Classification of Headache Disorders, 2nd ed – revision of criteria for 8.2 Medication-overuse headacheCephalalgia25460515910572
  • SmithTR2002Low-dose tizanidine with nonsteroidal anti-inflammatory drugs for detoxification from analgesic rebound headacheHeadache42175711903539
  • SmitsMGvan den MeerYGPfeilJPJM1994Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression testHeadache3410368163364
  • SpengosKTheleritisCPaparrigopoulosT2008Memantine and NMDA Antagonism for Chronic Migraine: A Potentially Novel Therapeutic Approach?Headache48284618194287
  • SteinerTJFindleyLJYuenAW1997Lamotrigine versus placebo in the prophylaxis of migraine with and without auraCephalalgia17109129137848
  • SteinerTJScherAIStewartWF2003The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicityCephalalgia235192712950377
  • StewartWFStaffaJLiptonRB1997Familial risk of migraine: a population-based studyAnn Neurol41166729029065
  • StovnerLJHagenKJensenR2007The global burden of headache: a documentation of headache prevalence and disability worldwideCephalalgia2719321017381554
  • StrengALindeKHoppeA2006Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxisHeadache46149250217115982
  • SzekelyBMeerymanSPostG1989Prophylactic effects of naproxen sodium on perimenstrual headache: a double-blind, placebo-controlled studyCephalalgia94523
  • Tfelt-HansenPBlockGDahlöfC2000bGuidelines for controlled trials of drugs in migraine: second editionCephalalgia207658611167908
  • Tfelt-HansenPSaxenaPRDahlofC2000aErgotamine in the acute treatment of migraine: a review and European consensusBrain12391810611116
  • The International Classification of Headache Disorders 2nd ed (ICHD-II)Cephalalgia200424Suppl 11160
  • TrautmannELackschewitzHKröner-HerwigB2006Psychological treatment of recurrent headache in children and adolescents – a meta-analysisCephalalgia2614112617116091
  • TronvikEStovnerLJHeldeG2003Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomised controlled trialJAMA28965912503978
  • VincentMBHadjikhaniN2007Migraine aura and related phenomena: beyond scotoma and scintillationsCephalalgia2713687717944958
  • WinnerPRothnerADSaperJ2000A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescentsPediatrics1069899711061765
  • ZwartJADybGHolmenTL2004The prevalence of migraine and tension-type headaches among adolescents in Norway. The Nord-Trøndelag Health Study (Head-HUNT-Youth), a large population-based epidemiological studyCephalalgia24373915096226

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.